NCT00461110View on ClinicalTrials.gov

A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)

PHASE1TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

BMS-663513

mg/kg, IV, 0.3, 1,3,6,10 mg/kg, q 3 wks, 12 weeks

Trial Locations (4)

10016

Nyu Clinical Cancer Center, New York

19107

Thomas Jefferson Univ Hospital, Philadelphia

75390

University Of Texas Southwestern Medical Center, Dallas

08901

The Cancer Institute Of New Jersey, New Brunswick

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY